51 – 60 of 382
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
- Contribution to journal › Article
-
Mark
C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury
- Contribution to journal › Article
-
Mark
C-reactive protein boosts antibody-mediated platelet destruction
- Contribution to journal › Scientific review
- 2014
-
Mark
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
- Contribution to journal › Article
-
Mark
Risk of RAS in relapsed childhood ALL.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
- Contribution to journal › Article
-
Mark
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
- Contribution to journal › Article
-
Mark
HIF-1α can act as a tumor suppressor gene in murine Acute Myeloid Leukemia.
- Contribution to journal › Article
-
Mark
Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
- Contribution to journal › Article